Bronson Crouch

CIK: 0001851041

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TIL

Instil Bio, Inc.

DirectorOfficer10% Owner

Discretionary Trading P&L

Holdings

Transaction History (2 total)

TIL
Instil Bio, Inc.
Apr 25, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
105.2K shares-
TIL
Instil Bio, Inc.
Sep 18, 2024
Award(A)
Employee Stock Option (right to buy)
Direct
50K shares-

		Type	Shares	Price		Ownership
Apr 25, 2025	TIL Instil Bio, Inc.	Award(A) Employee Stock Option (right to buy)	105,157	-	-	Direct
Sep 18, 2024	TIL Instil Bio, Inc.	Award(A) Employee Stock Option (right to buy)	50,000	-	-	Direct

1-2 of 2 transactions

About Crouch Bronson

Crouch Bronson (SEC CIK 0001851041) files insider reports with the SEC as CEO and Chairman of Instil Bio, Inc. (TIL).

Signal8 holds 2 ownership filings by Crouch Bronson, all Form 4s, filed between Sep 23, 2024 and Apr 28, 2025. Those filings report 2 transactions, from Sep 18, 2024 to Apr 25, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Crouch Bronson's filings is in DALLAS, TX.

Recent filings by Crouch Bronson

Apr 25, 2025: Grant or award of TIL derivative securities (Form 4, code A).
Sep 18, 2024: Grant or award of TIL derivative securities (Form 4, code A).

Other insiders filing for Instil Bio, Inc. (TIL)

McGaughy R Kent Jr, Director
Matcham George, Director
Gibson Neil W, Director
Binder Gwendolyn, Director
Laumas Sandeep, CFO and CBO

How to read Form 4 transaction codes